Global Mebendazole Market Growth 2025-2031
Description
The global Mebendazole market size is predicted to grow from US$ 128 million in 2025 to US$ 180 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for =2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
LP Information, Inc. (LPI) ' newest research report, the “Mebendazole Industry Forecast” looks at past sales and reviews total world Mebendazole sales in 2024, providing a comprehensive analysis by region and market sector of projected Mebendazole sales for 2025 through 2031. With Mebendazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mebendazole industry.
This Insight Report provides a comprehensive analysis of the global Mebendazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mebendazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mebendazole market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mebendazole and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mebendazole.
This report presents a comprehensive overview, market shares, and growth opportunities of Mebendazole market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tablet
Oral Suspension
Segmentation by Application:
Below 2 Years Old
Above 2 Years Old
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Key Questions Addressed in this Report
What is the 10-year outlook for the global Mebendazole market?
What factors are driving Mebendazole market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mebendazole market opportunities vary by end market size?
How does Mebendazole break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for =2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
LP Information, Inc. (LPI) ' newest research report, the “Mebendazole Industry Forecast” looks at past sales and reviews total world Mebendazole sales in 2024, providing a comprehensive analysis by region and market sector of projected Mebendazole sales for 2025 through 2031. With Mebendazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mebendazole industry.
This Insight Report provides a comprehensive analysis of the global Mebendazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mebendazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mebendazole market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mebendazole and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mebendazole.
This report presents a comprehensive overview, market shares, and growth opportunities of Mebendazole market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tablet
Oral Suspension
Segmentation by Application:
Below 2 Years Old
Above 2 Years Old
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Key Questions Addressed in this Report
What is the 10-year outlook for the global Mebendazole market?
What factors are driving Mebendazole market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mebendazole market opportunities vary by end market size?
How does Mebendazole break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
104 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Mebendazole by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Mebendazole by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
